Sana reports Q2 2026 progress on SC451, SG293 as Mayo Clinic invests $25M
Sana said it expects an SC451 IND filing and Phase 1/2 start this year, alongside first-in-human SG293 data, with cash runway into mid-2027.
SEC filing
Latest
1 story
Sign inSign in1 story
Sana said it expects an SC451 IND filing and Phase 1/2 start this year, alongside first-in-human SG293 data, with cash runway into mid-2027.
SEC filing